APN News: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018
ZIM Laboratories Limited (ZIM) – is a unique R&D centered
pharmaceutical company focused on developing and supply of complex
generics products based on proprietary Novel Drug Delivery Solutions
(NDDS).
Promoted by Technocrat Dr. Anwar Daud, the company has a Unique R&D focused business model helping customers with product development, co-development, out licensing, manufacturing, supplies and marketing support with a strong IP base – 26 inventions with 53 patent filings and 174 clients across 45 countries.
Original Article
Promoted by Technocrat Dr. Anwar Daud, the company has a Unique R&D focused business model helping customers with product development, co-development, out licensing, manufacturing, supplies and marketing support with a strong IP base – 26 inventions with 53 patent filings and 174 clients across 45 countries.
Original Article
Comments
Post a Comment